rs2234678

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000259206.9(IL1RN):​c.-31A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.244 in 1,357,394 control chromosomes in the GnomAD database, including 43,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4081 hom., cov: 33)
Exomes 𝑓: 0.25 ( 39308 hom. )

Consequence

IL1RN
ENST00000259206.9 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.25

Publications

21 publications found
Variant links:
Genes affected
IL1RN (HGNC:6000): (interleukin 1 receptor antagonist) The protein encoded by this gene is a member of the interleukin 1 cytokine family. This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses, particularly in the acute phase of infection and inflammation. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures and gastric cancer. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]
IL1RN Gene-Disease associations (from GenCC):
  • sterile multifocal osteomyelitis with periostitis and pustulosis
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-113117988-A-G is Benign according to our data. Variant chr2-113117988-A-G is described in ClinVar as Benign. ClinVar VariationId is 330820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.271 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL1RNNM_173841.3 linkc.-31A>G 5_prime_UTR_variant Exon 1 of 6 NP_776213.1 P18510-3
IL1RNNM_000577.5 linkc.-31A>G 5_prime_UTR_variant Exon 1 of 5 NP_000568.1 P18510-2
IL1RNNM_001318914.2 linkc.-313A>G 5_prime_UTR_variant Exon 1 of 7 NP_001305843.1 P18510-4A0A024R528

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL1RNENST00000259206.9 linkc.-31A>G 5_prime_UTR_variant Exon 1 of 6 1 ENSP00000259206.5 P18510-3
IL1RNENST00000354115.6 linkc.-31A>G 5_prime_UTR_variant Exon 1 of 5 1 ENSP00000329072.3 P18510-2
IL1RNENST00000361779.7 linkc.-250A>G 5_prime_UTR_variant Exon 1 of 6 1 ENSP00000354816.3 P18510-4

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31808
AN:
152080
Hom.:
4074
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0582
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.277
Gnomad ASJ
AF:
0.294
Gnomad EAS
AF:
0.0973
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.304
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.269
Gnomad OTH
AF:
0.230
GnomAD2 exomes
AF:
0.253
AC:
63655
AN:
251438
AF XY:
0.256
show subpopulations
Gnomad AFR exome
AF:
0.0510
Gnomad AMR exome
AF:
0.321
Gnomad ASJ exome
AF:
0.300
Gnomad EAS exome
AF:
0.0923
Gnomad FIN exome
AF:
0.304
Gnomad NFE exome
AF:
0.265
Gnomad OTH exome
AF:
0.265
GnomAD4 exome
AF:
0.248
AC:
299099
AN:
1205194
Hom.:
39308
Cov.:
17
AF XY:
0.249
AC XY:
152795
AN XY:
612620
show subpopulations
African (AFR)
AF:
0.0465
AC:
1353
AN:
29102
American (AMR)
AF:
0.315
AC:
13991
AN:
44386
Ashkenazi Jewish (ASJ)
AF:
0.287
AC:
7024
AN:
24494
East Asian (EAS)
AF:
0.0828
AC:
3195
AN:
38602
South Asian (SAS)
AF:
0.273
AC:
22113
AN:
81086
European-Finnish (FIN)
AF:
0.296
AC:
15735
AN:
53168
Middle Eastern (MID)
AF:
0.210
AC:
1112
AN:
5286
European-Non Finnish (NFE)
AF:
0.253
AC:
222104
AN:
877310
Other (OTH)
AF:
0.241
AC:
12472
AN:
51760
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
10841
21682
32524
43365
54206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6524
13048
19572
26096
32620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.209
AC:
31825
AN:
152200
Hom.:
4081
Cov.:
33
AF XY:
0.212
AC XY:
15779
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0581
AC:
2415
AN:
41570
American (AMR)
AF:
0.278
AC:
4253
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
1019
AN:
3470
East Asian (EAS)
AF:
0.0968
AC:
502
AN:
5188
South Asian (SAS)
AF:
0.283
AC:
1365
AN:
4818
European-Finnish (FIN)
AF:
0.304
AC:
3215
AN:
10568
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.269
AC:
18281
AN:
67972
Other (OTH)
AF:
0.232
AC:
489
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1255
2511
3766
5022
6277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.251
Hom.:
5893
Bravo
AF:
0.199
Asia WGS
AF:
0.195
AC:
679
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 49% of patients studied by a panel of primary immunodeficiencies. Number of patients: 47. Only high quality variants are reported. -

Sterile multifocal osteomyelitis with periostitis and pustulosis Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.39
DANN
Benign
0.71
PhyloP100
-1.3
PromoterAI
0.099
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234678; hg19: chr2-113875565; COSMIC: COSV52080796; COSMIC: COSV52080796; API